Drug Database
FA

Factor VIII (HemoRel)

✓ Approved

Reliance Life Sciences Private Limited · F8 · 细胞治疗

什么是 Factor VIII?

Factor VIII 是一种细胞治疗,由Reliance Life Sciences Private Limited研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名HemoRel
公司Reliance Life Sciences Private Limited
药物类别细胞治疗
分子靶点F8
给药途径Injectable (Others), Intravenous (IV)
状态Approved

作用机制

分子靶点

Factor VIII 作用于 1 个分子靶点:

F8coagulation factor VIII (AHF, FVIII)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

Factor VIII 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Congenital, familial and genetic disordersFactor VIII deficiency✓ Approved

相关研究文献

PubMedJournal of veterinary emergency and critical care (San Antonio, Tex. : 2001)2026-11-17

Acute Tracheal Narrowing due to Suspected Intramural Tracheal Hemorrhage in a Dog With Hemophilia A.

Kang Aileen A, Gonzalez Anthony L AL, Mazzaferro Elisa M EM

To describe a case of spontaneous intramural tracheal hemorrhage with subsequent tracheal narrowing leading to a respiratory crisis in a dog with hemophilia A (factor VIII deficiency). A 5-year-old neutered male Havanese presented in respiratory distress following acute-onset cough. The dog had a known history of hemophilia A and had been evaluated at a different facility the day prior, where thoracic radiographs showed severe tracheal attenuation, leading to a presumptive diagnosis of tracheal collapse. The patient was intubated on presentation due to severe respiratory distress. Serial blood work monitoring showed development of anemia and a prolonged activated partial thromboplastin time. Intramural tracheal hemorrhage was suspected, and a cryoprecipitate transfusion was administered. Subsequent thoracic radiographs at the 1-week follow-up showed improving tracheal attenuation, with complete resolution of tracheal narrowing. In hindsight, having a high index of suspicion of hemorrhage as the cause of respiratory distress at first presentation, and early transfusion of a factor VIII-containing blood product, would have likely reduced the progression and severity of the clinical episode in this dog. Intramural tracheal hemorrhage can present similarly to tracheal collapse and is a differential for tracheal narrowing on radiographs. There have been previous reports of dogs in respiratory distress with tracheal narrowing due to hemorrhage caused by anticoagulant rodenticide toxicosis. This is the first case report documenting spontaneous hemorrhage secondary to hemophilia A causing tracheal narrowing. Although rare, hemorrhage should be considered in all cases of tracheal narrowing, especially in patients without a chronic history of cough and those that fail to respond to standard treatment for tracheal collapse. Dogs with a known diagnosis of hemophilia A should be assumed to have bleeding almost regardless of their clinical presentation and treated accordingly.

PMID 43041205
阅读全文 →
PubMedCureus2026-11-17

Acquired Hemophilia A: A Case Report and Literature Review on a Diagnostic and Therapeutic Conundrum.

Stanley Ann M AM, Kakkar Shruti S, Chugh Sanjoli S, Mittal Tushar T et al.

Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder in which the body spontaneously produces inhibitory antibodies against coagulation factor VIII. This leads to severe, potentially life-threatening bleeding in patients who have no personal or family history of bleeding problems. The condition carries substantial mortality and remains difficult to diagnose and treat, especially in resource-limited settings. Here, we present three consecutive patients with AHA who were managed at a tertiary hematology center in northern India between 2016 and 2026. Each case illustrates a clinically distinct presentation and a different treatment course. The first patient was a 24-year-old man with pemphigus foliaceus and a history of Castleman disease previously treated with rituximab. Hemostasis was achieved with factor eight inhibitor bypassing activity (FEIBA), an activated prothrombin complex concentrate, but he developed refractory disease, with his inhibitor titer rising more than 20-fold from 16 to 332 Bethesda units (BU) despite first-line prednisolone and cyclophosphamide, after which second-line rituximab was started. Emicizumab was recommended for long-term hemostatic prophylaxis, but the patient was unable to access it due to financial constraints, and he was subsequently lost to follow-up. The second patient was a 35-year-old previously healthy man who presented with a post-traumatic popliteal hematoma and hematuria. Following treatment with prednisolone and cyclophosphamide, the inhibitor became undetectable at eight months, and he was in clinical remission; complete remission could not be confirmed because factor VIII activity was not reassessed. He was subsequently lost to follow-up. The third patient was a 75-year-old woman with longstanding diabetes mellitus and hypertension. She presented with a sudden-onset sublingual hematoma, and high-resolution computed tomography (HRCT) confirmed epiglottic and hypopharyngeal wall thickening causing narrowing of the supraglottic airway. Hemostasis was achieved with FEIBA, alongside prednisolone and subsequent outpatient rituximab, and she was discharged. Approximately four months after discharge, and at least four months after the last FEIBA dose, she suffered an acute myocardial infarction, and her family subsequently chose comfort-focused care. This report underscores the wide clinical variability of AHA, the importance of thorough coagulation workup in any unexplained bleeding episode, the difficulties of managing refractory inhibitor disease in resource-limited settings, and the critical value of HRCT when evaluating hematomas located near the airway.

PMID 43041933
阅读全文 →
PubMedGenes & diseases2026-11-17

The NEIL DNA glycosylase family: Molecular mechanisms, disease relevance, and therapeutic potential.

Ma Chi C, Ma Yukang Y, Zeng Yanqiong Y, Li Ziyue Z et al.

Mammalian genomes are continually challenged by endogenous and exogenous stressors that generate oxidative DNA lesions and threaten genome stability, making the base excision repair (BER) pathway indispensable for safeguarding against mutagenesis and cell dysfunction. Within BER cascade, the Nei endonuclease VIII-like (NEIL) glycosylases, including NEIL1, NEIL2, and NEIL3, have evolved as multifunctional, context-dependent regulators: beyond their canonical role of excising oxidized bases, they bridge BER to replication-associated genome maintenance (particularly NEIL1 and NEIL3), transcription-coupled repair (especially NEIL2), mitochondrial homeostasis, chromatin-associated processes, immune modulation, and epigenetic remodeling. In this review, we provide an integrated synthesis of the genomic architecture, structural features, catalytic preferences, and interaction networks of NEIL1-3, and summarize mechanistic and clinical evidence implicating their dysregulation in a broad spectrum of human diseases. We further highlight how altered NEIL expression, genetic variation, and regulatory perturbations shape tumor phenotypes, mutation load, therapy response, and clinical outcomes across diverse cancers, while also influencing neurodegeneration and stroke, cardiovascular injury and atherogenesis, infection-associated inflammation, and systemic autoimmunity. Finally, we discuss translational opportunities centered on NEIL proteins, such as their emerging utility as disease biomarkers and early advances in small-molecule inhibition, and highlight unmet challenges: the need to account for cell-type-specific activity, define safe and effective therapeutic windows, and develop isoform-selective targeting strategies that preserve essential genome surveillance in normal tissues.

PMID 43041594
阅读全文 →
PubMedPsychology and psychotherapy2026-11-17

Epistemic mistrust as a correlate of general psychopathology (p-factor) in adolescence: Evidence from community and clinical samples.

Locati Francesca F, Aynaudi Matteo M, Ensink Karin K, Fonagy Peter P et al.

The psychological processes underlying broad psychopathological liability in adolescence, indexed by the p-factor, remain underspecified. Within the mentalising framework, epistemic trust refers to the capacity to regard communicated information as reliable, personally relevant and generalisable; its disruptions, expressed as Epistemic Mistrust or Credulity, may limit adaptive social learning and contribute to transdiagnostic vulnerability. We examined whether epistemic stances were associated with the p-factor in adolescence and whether these associations differed between community and clinical samples. Cross-sectional study of 1073 Italian adolescents (846 community, 227 clinical; Mage = 15.30, SD = 1.89). General psychopathology was estimated via a bifactor model based on YSR syndrome subscales; Epistemic Trust, Mistrust and Credulity were assessed by self-report (ETMCQ). Structural equation modelling tested associations between latent epistemic dimensions and estimated p-factor scores in the full sample and across groups. In the full model, lower Trust and higher Mistrust and Credulity were each significantly associated with higher general psychopathology. Multi-group analyses indicated non-equivalent associations across groups, and path-by-path tests located this difference in Trust alone (Δχ2(1) = 9.30, p = .002); the Mistrust and Credulity coefficients did not differ between groups. Epistemic mistrust was associated with general psychopathology to a comparable degree in both community and clinical adolescents, as was epistemic credulity. The association involving Trust was present only among community adolescents, and this was the single group difference that survived formal testing.

PMID 43040793
阅读全文 →
PubMedPhysiotherapy theory and practice2026-11-17

Fatigue response of the quadriceps to neuromuscular electrical stimulation in resistance trained versus untrained subjects.

Bellew James W JW, Deno Ella E, Madden Colin C, Marshall Isaac I et al.

A variety of different neuromuscular electrical stimulation (NMES) waveforms are used in clinical practice, yet limited data are available that have examined the fatigue response (FR) of muscle to these waveforms. Even less is known regarding the effects of resistance training on FR during NMES. This study was designed to examine FR in resistance trained versus untrained subjects, using two common NMES waveforms. Twenty young adults (13 male, 7 female; 23 ± 2 y/o) were assigned to resistance‑trained (RT, n = 10) or untrained (UT, n = 10) groups. FR of the dominant quadriceps was calculated as the percentage decrease in electrically elicited force (EEF) between the highest and lowest repetitions over a single set of 10 repetitions using both Russian and symmetrical biphasic pulsed (SBP) waveforms. A two‑way repeated measures ANOVA was used to examine if training status or waveform affected the FR of the quadriceps. Training status was not a significant factor in FR (F = .532, p = .475), with RT subjects showing an average FR of 49.1% across both waveforms versus 52.7% in the UT. NMES waveform was not a significant factor in the FR (F = 2.816, p = .111) showing an average FR of 55% with Russian across both groups and 47% FR with SBP. Training status was also not a significant factor in peak EEF (F = .0433, p = .838), with an average 29.9 lb in the RT group and 28.5 lb in the UT. However, waveform was a significant factor in peak EEF, with SBP showing an average of 40.57 lb vs. 17.9 lb for Russian (F = 25.203, p < .001). Resistance training nor NMES waveform affected FR of the quadriceps over repeated electrically elicited contractions. Additionally, these data support previous studies reporting significantly less EEF with Russian versus SBP current.

PMID 43042895
阅读全文 →
PubMedItalian journal of dermatology and venereology2026-11-17

Cutaneous and systemic treatment-related adverse events as prognostic markers in immunotherapy and targeted therapy, with a focus on melanoma.

Crespi Orsola O, Santaniello Umberto U, Rosset François F, Pala Valentina V et al.

Immune checkpoint inhibitors (ICIs) and targeted therapies have transformed the management of advanced malignancies but are associated with characteristic adverse events (AEs), many of which are skin-predominant. Increasing evidence indicates that selected treatment-related AEs, particularly immune-related adverse events (irAEs) and on-target toxicities, may serve as dynamic biomarkers of antitumor activity. This review summarizes current data on the incidence, spectrum, and prognostic significance of irAEs and targeted-therapy AEs, with a specific emphasis on cutaneous events relevant to dermatologists. We highlight the robust association between cutaneous irAEs (cirAEs) - including vitiligo, regression of melanocytic nevi and halo phenomena in melanoma - and improved clinical outcomes. We also examine prognostic data for other cutaneous patterns (lichenoid, psoriasiform, bullous), endocrine and other organ-specific irAEs, and on-target dermatologic toxicities under epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor (VEGFR), and BRAF/MEK inhibition. Finally, we discuss mechanistic hypotheses and practical implications for dermatology practice, stressing the need to balance recognition of toxicity as a favorable biomarker with timely management to avoid treatment interruption.

PMID 43043303
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Factor VIII